Is there a generic for Rapacuronium bromide?

The FDA Orange Book does not currently list an approved generic (ANDA) for Rapacuronium bromide. It is available as 1 brand (NDA) application.

What is the reference-listed drug for Rapacuronium bromide?

RAPLON (NDA 020984, ORGANON USA INC) is the reference-listed drug — the approved product a generic applicant must show its version is the same as.

What dosage forms of Rapacuronium bromide are approved?

Rapacuronium bromide is approved in the following dosage form: injectable.

FDA Orange Book · active-ingredient family

Rapacuronium bromide

Rapacuronium bromide is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.

Reference-listed drug:RAPLON · NDA 020984

Brand (NDA)

Generics (ANDA)

Listed patents

Exclusivity periods

Brand (NDA) products · injectable

Product	Applicant	Application	TE	Approved
RAPLON×2	ORGANON USA INC	NDA 020984	—	Aug 18, 1999

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Rapacuronium bromide — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo